An increase in circulating B cells and B cell activation markers in peripheral blood is associated with cigarette smoking in a male cohort in Bangladesh.

[1]  S. Bonovas,et al.  Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses. , 2019, Gastroenterology.

[2]  F. Parvez,et al.  Changes in human peripheral blood mononuclear cell (HPBMC) populations and T-cell subsets associated with arsenic and polycyclic aromatic hydrocarbon exposures in a Bangladesh cohort , 2019, PloS one.

[3]  S. Pierce,et al.  B cell signaling in context , 2019, Nature Immunology.

[4]  F. Parvez,et al.  Assessment of arsenic and polycyclic aromatic hydrocarbon (PAH) exposures on immune function among males in Bangladesh , 2019, PloS one.

[5]  S. Hecht,et al.  Recent Studies on DNA Adducts Resulting from Human Exposure to Tobacco Smoke , 2019, Toxics.

[6]  A. Hyland,et al.  Urinary concentrations of monohydroxylated polycyclic aromatic hydrocarbons in adults from the U.S. Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013–2014) , 2018, Environment international.

[7]  V. Cogliano.  International Agency for Research on Cancer (IARC) , 2018, The Grants Register 2019.

[8]  P. Vermersch,et al.  Altered B lymphocyte homeostasis and functions in systemic sclerosis. , 2018, Autoimmunity reviews.

[9]  F. Lauer,et al.  Isolation, Cryopreservation, and Immunophenotyping of Human Peripheral Blood Mononuclear Cells , 2017, Current protocols in toxicology.

[10]  E. Karlson,et al.  Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts , 2017, Annals of the rheumatic diseases.

[11]  F. Lauer,et al.  Intracellular Cytokine Detection by Flow Cytometry in Surface Marker‐Defined Human Peripheral Blood Mononuclear T Cells , 2017, Current protocols in toxicology.

[12]  M. Barbhaiya,et al.  Understanding the role of environmental factors in the development of systemic lupus erythematosus. , 2017, Best practice & research. Clinical rheumatology.

[13]  Wei Jiang,et al.  The Other Function: Class II-Restricted Antigen Presentation by B Cells , 2017, Front. Immunol..

[14]  A. Bossios,et al.  Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis. , 2017, Journal of autoimmunity.

[15]  Feifei Qiu,et al.  Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? , 2016, Oncotarget.

[16]  F. Lauer,et al.  Editor's Highlight: Interactive Genotoxicity Induced by Environmentally Relevant Concentrations of Benzo(a)Pyrene Metabolites and Arsenite in Mouse Thymus Cells. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  J. Schwartz,et al.  Short‐Term Exposure to Air Pollution and Biomarkers of Oxidative Stress: The Framingham Heart Study , 2016, Journal of the American Heart Association.

[18]  P. Jha,et al.  Exposure to Second-Hand Smoke and the Risk of Tuberculosis in Children and Adults: A Systematic Review and Meta-Analysis of 18 Observational Studies , 2015, PLoS medicine.

[19]  F. Lauer,et al.  Arsenite Interacts with Dibenzo[def,p]chrysene (DBC) at Low Levels to Suppress Bone Marrow Lymphoid Progenitors in Mice , 2015, Biological Trace Element Research.

[20]  K. Arheart,et al.  Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study , 2014, PloS one.

[21]  M. Stampfli,et al.  Continuous and Discontinuous Cigarette Smoke Exposure Differentially Affects Protective Th1 Immunity against Pulmonary Tuberculosis , 2013, PloS one.

[22]  Habibul Ahsan,et al.  The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem , 2013, Environmental health perspectives.

[23]  Robin B Harris,et al.  Gender Difference in Systemic Oxidative Stress and Antioxidant Capacity in Current and Former Heavy Smokers , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[24]  F. Parvez,et al.  Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study , 2010, The Lancet.

[25]  D. Postma,et al.  Increased levels of (class switched) memory B cells in peripheral blood of current smokers , 2009, Respiratory research.

[26]  M. Stämpfli,et al.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer , 2009, Nature Reviews Immunology.

[27]  L. Knudsen,et al.  Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. , 2008, International journal of hygiene and environmental health.

[28]  W. Tsai,et al.  Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. , 2008, Carcinogenesis.

[29]  R. Langley,et al.  T Cells Express α7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response1 , 2007, The Journal of Immunology.

[30]  F. Parvez,et al.  Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation , 2006, Journal of Exposure Science and Environmental Epidemiology.

[31]  M. D. Reed,et al.  Effect of cigarette smoke on autoimmunity in murine and human systemic lupus erythematosus. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[32]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[33]  H. Ahsan,et al.  Polycyclic aromatic hydrocarbon-DNA adducts among rickshaw drivers in Dhaka City, Bangladesh , 2003, International archives of occupational and environmental health.

[34]  R. Sinha,et al.  Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: validation by comparison with other methods, and use in human biomonitoring. , 2002, Carcinogenesis.

[35]  B. Beilin,et al.  Immune response in asymptomatic smokers , 2002, Acta anaesthesiologica Scandinavica.

[36]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[37]  M. Sopori,et al.  Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.

[38]  P. Strickland,et al.  Urinary 1-hydroxypyrene and other PAH metabolites as biomarkers of exposure to environmental PAH in air particulate matter. , 1999, Toxicology letters.

[39]  T. Schaberg,et al.  Lymphocyte Subsets in Peripheral Blood and Smoking Habits , 1997, Lung.

[40]  S. Burchiel,et al.  Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-naphthoflavone. , 1996, Toxicology and applied pharmacology.

[41]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[42]  J. M. Christensen,et al.  Estimation of reference values for urinary 1-hydroxypyrene and α-naphthol in Danish workers , 1995 .

[43]  E. Bleecker,et al.  Altered cytokine regulation in the lungs of cigarette smokers. , 1994, American journal of respiratory and critical care medicine.

[44]  J. Schwartz,et al.  Cigarette smoking and peripheral blood leukocyte differentials. , 1994, Annals of epidemiology.

[45]  F. Perera,et al.  Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  G. Varigos,et al.  IL‐4 production is increased in cigarette smokers , 1994, Clinical and experimental immunology.

[47]  P. Arlien‐Søborg,et al.  Science of the Total Environment , 2018 .

[48]  Zedeck Ms.  Polycyclic aromatic hydrocarbons: a review. , 1980 .

[49]  I. Weinstein,et al.  Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. , 1980, Cancer research.

[50]  S. Burchiel,et al.  Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. , 2010, IARC monographs on the evaluation of carcinogenic risks to humans.

[51]  S. Burchiel,et al.  Signaling by environmental polycyclic aromatic hydrocarbons in human lymphocytes. , 2001, Clinical immunology.

[52]  R Ottman,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells and urinary 1-hydroxypyrene in foundry workers. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  M. S. Zedeck,et al.  Polycyclic aromatic hydrocarbons: a review. , 1980, Journal of environmental pathology and toxicology.

[54]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.